Track the 바이오인프라생명과학 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이오인프라생명과학 has recorded 12 reports. The latest transaction was disclosed on 16 December 2024 (Purchase). Among the most active insiders: 이정호. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
12 of 12 declarations
BioInfra Life Science is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for medical needs.